India May Be Nearing Dispute Settlement With EU Over Generic Drug Seizures 28/08/2009 by Kaitlin Mara for Intellectual Property Watch Leave a Comment Ongoing concerns in India that their legitimate generic drug shipments are being delayed as potential counterfeits while in transit through Europe may reach the dispute settlement body at the World Trade Organization, according to sources.
EU, US Bristle As Drug Innovators Pay To Delay New Generics 25/08/2009 by Steven Seidenberg for Intellectual Property Watch Leave a Comment Authorities in the European Union and the United States have recently taken a tougher stance against reverse payments – patent settlements whereby, according to many competition experts, dominant drug companies buy off potential rivals.
Indian High Court Rejects Bayer Complaint For Patent Linkage 21/08/2009 by Monika Ermert for Intellectual Property Watch and Kaitlin Mara for Intellectual Property Watch 3 Comments Indian generics manufacturer Cipla can get marketing approval for its generic cancer treatment Soranib, the Delhi High Court ruled Tuesday, and the Indian drug regulatory authority does not have to check its patent status first. The court this week rejected a complaint by drug multinational Bayer against the Union of India, the Drug Controller General of India and generic drug producer Cipla. Bayer sought a court order requiring DCGI to consider the patent status of kidney cancer drug, sorafenib tosylate (sold under the brand name Nexavar), before granting marketing approval for a generic version of the drug. At issue was whether it is legitimate to link a potential violation of IP rights to processes regulating a drug’s entry onto the market that are generally based on drug quality, efficacy and safety.
美国最高法院复审比尔斯基案可能震动专利制度 12/08/2009 by Steven Seidenberg for Intellectual Property Watch Leave a Comment 去年10月，一家美国上诉法院极大地改变了美国的专利法，从而在就何种发明能够受到专利保护这一问题上采取的做法更接近其他国家的标准。联邦上诉巡回法庭（Federal Circuit Court of Appeals，经常被称为美国的“专利法庭”）撤销了自己基本判例，并大幅减少了符合专利保护各类方法和程序。该判决使数千个专利前途未卜，其中就包括许多商业方法专利和金融方法专利。
La revisión del caso Bilski por parte de la Corte Suprema de los EE.UU. podría repercutir en todo el sistema de patentes 12/08/2009 by Steven Seidenberg for Intellectual Property Watch Leave a Comment El pasado mes de octubre, un tribunal de apelación de los Estados Unidos modificó drásticamente la ley de patentes, acercando así las normas de este país a las de otros en lo relativo a las invenciones que se pueden patentar. El Tribunal de Apelación del Circuito Federal (apodado a menudo el “tribunal de patentes” de los EE.UU) anuló uno de sus precedentes fundamentales y redujo fuertemente los tipos de métodos y procesos que pueden ser objeto de protección mediante patentes. La decisión dejó en entredicho a miles de patentes, entre ellas muchas relacionadas con métodos comerciales y métodos financieros.
Le réexamen de l’affaire Bilski par la Cour suprême américaine pourrait avoir des répercussions sur le système des brevets 12/08/2009 by Steven Seidenberg for Intellectual Property Watch Leave a Comment En octobre dernier, aux États-Unis, l’arrêt rendu par une cour d’appel a bouleversé la loi fédérale sur les brevets, en comblant le fossé qui la séparait des législations d’autres pays sur les critères de brevetabilité des inventions. La Cour d’appel du tribunal fédéral (Federal Circuit Court of Appeals, parfois surnommée « tribunal de la propriété intellectuelle ») a annulé sa propre décision qui faisait école jusque là. Elle a, de plus, drastiquement limité les types de méthodes et de procédés brevetables. L’arrêt de la cour a remis en question des milliers de brevets, portant pour un grand nombre d’entre eux sur des méthodes commerciales et des procédés financiers.
Members Of Human Rights Expert Committee At UN Question Patents On Food 07/08/2009 by Kaitlin Mara for Intellectual Property Watch 7 Comments A group of experts working as a think-tank for the United Nations Human Rights Council raised the issue of patents and food at a meeting this week. Meanwhile, a new report by the UN Special Rapporteur on the Right to Food expected to be available at the end of August will focus on the intersection between intellectual property and the human right to food.
ECOSOC Wraps Up With Discussion Of Environmental Governance Framework 04/08/2009 by Catherine Saez, Intellectual Property Watch 2 Comments The influential United Nations Economic and Social Council (ECOSOC) ended its 2009 substantive session on 31 July, after a month-long coordinating body meeting in Geneva which yielded resolutions on several topics such as public health, science and technology, human rights, environment and sustainable development issues.
Financial Services, Patent Experts Seek More Certainty On Business-Method Patents, Bilski Case 31/07/2009 by Liza Porteus Viana, Intellectual Property Watch 2 Comments NEW YORK – Patent lawyers from financial services companies and other firms this week said they are hopeful that change at the US Patent and Trademark Office will bring solutions to their concerns with the business method patents, application backlogs, patent quality problems, transparency and other issues.
US Supreme Court Review Of Bilski Could Reverberate Through Patent System 31/07/2009 by Steven Seidenberg for Intellectual Property Watch 1 Comment Last October, a United States appellate court shifted the country’s patent law dramatically, moving the nation closer to other countries’ standards on what inventions can be patented. The Federal Circuit Court of Appeals (often called America’s “patent court”) overruled its own seminal precedent and sharply cut back on the types of methods and processes that are eligible for patent protection. The ruling put thousands of patents under a cloud, including many business method patents and financial method patents. This controversial ruling will soon be reviewed by the US Supreme Court. The resulting decision in Bilski v. Doll could become a milestone in US patent law, with repercussions around the world.